Literature DB >> 14665621

Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.

Yuan Ren1, Songshu Meng, Lin Mei, Z Joe Zhao, Richard Jove, Jie Wu.   

Abstract

Epidermal growth factor (EGF) induces paxillin tyrosine dephosphorylation and Src activation, but the signaling pathways that mediate these responses were largely undefined. We found that Gab1, a docking protein for the SHP2 protein-tyrosine phosphatase in EGF-stimulated cells, was associated with paxillin. SHP2 dephosphorylated paxillin and caused dissociation of Csk, a negative regulator of Src, from paxillin but had no effect on paxillin-Src association. A lower level of Src Tyr-530 phosphorylation was detected in paxillin-associated Src in EGF-stimulated cells. Expression of an SHP2 binding defective mutant of Gab1 (Gab1FF) or a catalytically inactive mutant of SHP2 (SHP2DN) prevented paxillin tyrosine dephosphorylation and Src activation induced by EGF. Importantly, Gab1FF blocked paxillin-SHP2 complex formation, Src Tyr-530 dephosphorylation, Erk activation, and cell migration induced by EGF. Inhibition of Src tyrosine kinase activity abrogated EGF-stimulated Erk activation and cell migration. Together, these results reveal that Gab1 recruits SHP2 to dephosphorylate paxillin, leading to dissociation of Csk from the paxillin-Src complex and Src activation and that Src is an SHP2 effector involved in EGF-stimulated Erk activation and cell migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14665621     DOI: 10.1074/jbc.M312575200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2.

Authors:  Hla Win-Piazza; Valentina E Schneeberger; Liwei Chen; Daniele Pernazza; Harshani R Lawrence; Said M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Cancer Lett       Date:  2012-02-01       Impact factor: 8.679

Review 2.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

3.  Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL.

Authors:  Yuan Ren; Zhengming Chen; Liwei Chen; Nicholas T Woods; Gary W Reuther; Jin Q Cheng; Hong-gang Wang; Jie Wu
Journal:  J Biol Chem       Date:  2007-10-17       Impact factor: 5.157

4.  TIMP-2 upregulates RECK expression via dephosphorylation of paxillin tyrosine residues 31 and 118.

Authors:  J Oh; T Diaz; B Wei; H Chang; M Noda; W G Stetler-Stevenson
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

5.  Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.

Authors:  Fern Sha; Emel Basak Gencer; Sandrine Georgeon; Akiko Koide; Norihisa Yasui; Shohei Koide; Oliver Hantschel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

6.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

7.  Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking.

Authors:  Klaus Hellmuth; Stefanie Grosskopf; Ching Tung Lum; Martin Würtele; Nadine Röder; Jens Peter von Kries; Marta Rosario; Jörg Rademann; Walter Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

8.  Ajuba functions as a histone deacetylase-dependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor.

Authors:  Diego E Montoya-Durango; Chinavenmeni S Velu; Avedis Kazanjian; Meghan E B Rojas; Chris M Jay; Gregory D Longmore; H Leighton Grimes
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

9.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

10.  Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations.

Authors:  Zhi-Hong Yu; Jie Xu; Chad D Walls; Lan Chen; Sheng Zhang; Ruoyu Zhang; Li Wu; Lina Wang; Sijiu Liu; Zhong-Yin Zhang
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.